LAURA TOPPEN: Open Payments
NPI 1326563495 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 21 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $46 · 2025 $1,088
Food & beverage: $691Travel & lodging: $397
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 8 | $641 |
| GENZYME CORPORATION | 2 | $156 |
| HARMONY BIOSCIENCES LLC | 2 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| United Therapeutics Corporation | 1 | $32 |
| Verona Pharma, Inc. | 1 | $30 |
| Insmed, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: INSPIRE, DUPIXENT, WAKIX, GLASSIA, Tyvaso, Ohtuvayre, BREZTRI, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
